Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal–fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis
Authors:
Open Access
- 4 August 2020
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 302 (6) , 1353-1359
Abstract
Purpose: To determine the frequency of fetal infection as well as adverse pregnancy outcomes following antenatal hyperimmunoglobulin (HIG) treatment for primary cytomegalovirus (CMV) infection in pregnancy. Methods: In our observational cohort study, data from 46 women with a primary CMV infection during pregnancy were evaluated. Primary CMV infection was defined by seroconversion or the presence of CMV-IgM and low CMV-IgG avidity. All women received at least two or more infusions of HIG treatment (200 IU/kg). Congenital CMV infection (cCMV) was diagnosed by detection of CMV in amniotic fluid and/or neonatal urine. We compared the rate of maternal–fetal transmission from our cohort to data without treatment in the literature. The frequency of adverse pregnancy outcomes was compared to those of live-born infants delivered in our clinic. Results: We detected 11 intrauterine infections in our cohort, which correlates to a transmission rate of 23.9%. Compared to the transmission rate found in cases without treatment (39.9%), this is a significant reduction (P = 0.026). There were no adverse pregnancy outcomes in our cohort. The mean gestational age at delivery was 39 weeks gestation in treatment and control group. Conclusion: The administration of HIG for prevention of maternal–fetal CMV transmission during pregnancy seems safe and effective.Keywords
This publication has 29 references indexed in Scilit:
- A series of 238 cytomegalovirus primary infections during pregnancy: description and outcomePrenatal Diagnosis, 2013
- Risk of cytomegalovirus‐associated sequelae in relation to time of infection and findings on prenatal imagingUltrasound in Obstetrics & Gynecology, 2013
- Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational ageJournal of Clinical Virology, 2011
- Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnanciesAmerican Journal of Obstetrics and Gynecology, 2011
- Attribution of Congenital Cytomegalovirus Infection to Primary Versus Non-Primary Maternal InfectionClinical Infectious Diseases, 2010
- Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infectionReviews in Medical Virology, 2007
- Analyse des Neugeborenenkollektivs der Bundesrepublik DeutschlandGeburtshilfe und Frauenheilkunde, 2006
- Pre‐ and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital diseaseBJOG: An International Journal of Obstetrics & Gynaecology, 2005
- Recurrent cytomegalovirus infection during pregnancy: ultrasonographic diagnosis and fetal outcomeUltrasound in Obstetrics & Gynecology, 2002
- The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody StatusNew England Journal of Medicine, 1992